Ahola T - Search Results

1

Pharmacokinetics of intravenous N-acetylcysteine in pre-term new-born infants.

Ahola T, Fellman V, Laaksonen R, Laitila J, Lapatto R, Neuvonen PJ, Raivio KO. Ahola T, et al. Eur J Clin Pharmacol. 1999 Nov;55(9):645-50. doi: 10.1007/s002280050687. Eur J Clin Pharmacol. 1999. PMID: 10638393 Clinical Trial.

2

N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial.

Ahola T, Lapatto R, Raivio KO, Selander B, Stigson L, Jonsson B, Jonsbo F, Esberg G, Stövring S, Kjartansson S, Stiris T, Lossius K, Virkola K, Fellman V. Ahola T, et al. J Pediatr. 2003 Dec;143(6):713-9. doi: 10.1067/S0022-3476(03)00419-0. J Pediatr. 2003. PMID: 14657813 Clinical Trial.

3

[N-Acetylcysteine: new possibilities to use an old substance].

Ahola T, Lapatto R. Ahola T, et al. Duodecim. 1999;115(4):375-9. Duodecim. 1999. PMID: 11830885 Review. Finnish. No abstract available.

4

Thiol metabolism in preterm infants during the first week of life.

Ahola T, Levonen AL, Fellman V, Lapatto R. Ahola T, et al. Scand J Clin Lab Invest. 2004;64(7):649-58. doi: 10.1080/00365510410002959. Scand J Clin Lab Invest. 2004. PMID: 15513322

5

Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia.

Ahola T, Fellman V, Kjellmer I, Raivio KO, Lapatto R. Ahola T, et al. Pediatr Res. 2004 Jul;56(1):88-93. doi: 10.1203/01.PDR.0000130478.05324.9D. Epub 2004 May 5. Pediatr Res. 2004. PMID: 15128912 Clinical Trial.

6

Postnatal N‑acetylcysteine does not provide neuroprotection in extremely low birth weight infants: A follow-up of a randomized controlled trial.

Kiuru A, Ahola T, Klenberg L, Tommiska V, Lano A, Kleemola P, Haavisto A, Fellman V. Kiuru A, et al. Among authors: ahola t. Early Hum Dev. 2019 May;132:13-17. doi: 10.1016/j.earlhumdev.2019.03.006. Epub 2019 Mar 28. Early Hum Dev. 2019. PMID: 30927687 Clinical Trial. No abstract available.

7

Corrigendum to "Postnatal N-acetylcysteine does not provide neuroprotection in extremely low birth weight infants: A follow-up of a randomized controlled trial" [Early Hum. Dev. 132(2019) 13-17].

Kiuru A, Ahola T, Klenberg L, Tommiska V, Lano A, Kleemola P, Haavisto A, Fellman V. Kiuru A, et al. Among authors: ahola t. Early Hum Dev. 2019 Jul;134:12. doi: 10.1016/j.earlhumdev.2019.05.004. Epub 2019 May 14. Early Hum Dev. 2019. PMID: 31100514 No abstract available.

8

Two alpha-chain hemoglobin variants, Hb Broussais and Hb Cemenelum, characterized by cation-exchange HPLC, isoelectric focusing, and peptide sequencing.

Turpeinen U, Sipilä I, Anttila P, Karjalainen U, Kuronen B, Kalkkinen N, Ahola T, Stenman UH. Turpeinen U, et al. Among authors: ahola t. Clin Chem. 1995 Apr;41(4):532-6. Clin Chem. 1995. PMID: 7720241

9

[Breaking the circle of aggression: victim, aggressor and network].

Furman B, Ahola T. Furman B, et al. Among authors: ahola t. Duodecim. 1992;108(3):304-10. Duodecim. 1992. PMID: 1366014 Review. Finnish. No abstract available.

10

Return of the question "why": advantages of exploring pre-existing explanations.

Furman B, Ahola T. Furman B, et al. Among authors: ahola t. Fam Process. 1988 Dec;27(4):395-409. doi: 10.1111/j.1545-5300.1988.00437.x. Fam Process. 1988. PMID: 3234526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters